A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: LY3549492;   Drug: Placebo;   Drug: Atorvastatin;   Drug: Midazolam Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2022 Category: Research Source Type: clinical trials

COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)
Condition:   Non ST Segment Elevation Acute Coronary Syndrome Interventions:   Drug: Colchicine;   Drug: Atorvastatin Sponsor:   Azienda USL Toscana Centro Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2022 Category: Research Source Type: clinical trials